Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge
| dc.contributor.author | Sánchez Cuerda, Cristina | |
| dc.contributor.author | Cuadra, María | |
| dc.contributor.author | Gamir Henderson, Susana | |
| dc.contributor.author | Lobo Abascal, Paloma | |
| dc.contributor.author | Elices Apellániz, Margarita | |
| dc.contributor.author | Cabrera Guerra, Yasmina | |
| dc.date.accessioned | 2022-07-27T18:57:27Z | |
| dc.date.available | 2022-07-27T18:57:27Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Objective: Adenocarcinoma in situ (AIS) of the cervix is a premalignant lesion, and a precursor of invasive disease. It is less frequent than its squamous counterpart. During pregnancy, AIS is a scarcely described scenario, whose diagnosis barely differs from non-pregnant patients. Its management is challenging with hysterectomy being the definitive treatment. However, its high incidence in young patients makes fertility-sparing management an approachable option for selected patients. The objective of this study is twofold. Firstly, we describe a case of a patient with AIS during pregnancy and the postpartum period. Secondly, the available literature is reviewed. Methods: Retrospective medical record review of a single case and a medical literature search in Pubmed of AIS cases in pregnant women. Results: A 31-year-old woman with cervical AIS diagnosed during pregnancy underwent serial fertility-sparing surgeries including a loop electrosurgical excision procedure and endocervical curettage during the second trimester, and a re-conization and a simple traquelectomy during the postpartum period, until negative margins were achieved. Upon reviewing the literature from 1965 to 2020, 23 other cases were found. Conclusion: Surgical management of cervical AIS during pregnancy is a safe procedure. Subsequent conservative surgeries imply a real challenge to preserve fertility. | spa |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 3.8 Q2 JCR 2022 | spa |
| dc.description.impact | 0.927 Q1 SJR 2022 | spa |
| dc.description.impact | No data IDR 2022 | spa |
| dc.description.sponsorship | Sin financiación | spa |
| dc.identifier.citation | Sánchez-Cuerda, C., Cuadra, M., Gámir, S., Lobo, P., Elices, M., & Cabrera, Y. (2022). Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge. International Journal of Gynecology and Obstetrics, 158(1), 21-26. https://doi.org/10.1002/ijgo.13948 | spa |
| dc.identifier.doi | 10.1002/ijgo.13948 | |
| dc.identifier.issn | 1879-3479 | |
| dc.identifier.issn | 0020-7292 | |
| dc.identifier.uri | http://hdl.handle.net/11268/11541 | |
| dc.language.iso | eng | spa |
| dc.peerreviewed | Si | spa |
| dc.relation.publisherversion | https://doi.org/10.1002/ijgo.13948 | spa |
| dc.rights.accessRights | restricted access | spa |
| dc.subject.other | Colposcopía | spa |
| dc.subject.other | Prueba de Papanicolaou | spa |
| dc.subject.other | Displasia del cuello del útero | spa |
| dc.subject.unesco | Salud | spa |
| dc.subject.unesco | Embarazo | spa |
| dc.subject.unesco | Cáncer | spa |
| dc.title | Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge | spa |
| dc.type | journal article | spa |
| dspace.entity.type | Publication |

